April 14th 2025, 1:02pm
April serves as Testicular Cancer Awareness Month, which is the most common type of cancer in men aged between 15 and 44 years old.
April 13th 2025, 6:00pm
The FDA previously granted breakthrough therapy designation to ziftomenib for relapsed/refractory NPM1-mutant AML.
April 13th 2025, 2:00pm
Based on the phase 3 CABINET trial, the FDA approved Cabometyx for some patients with previously treated neuroendocrine tumors.
April 12th 2025, 6:00pm
Use of NeuroSAFE during prostatectomy nearly doubled the number of patients who had no or mild erectile dysfunction approximately a year later.
April 12th 2025, 2:00pm
KSQ-004EX is being evaluated in solid tumors including melanoma, non-small cell lung, head and neck, colorectal, pancreatic and cervical cancer.
April 11th 2025, 9:00pm
Imdelltra is associated with improvement in overall survival compared to local standard-of-care chemotherapy among patients with small cell lung cancer.
April 11th 2025, 8:00pm
Some cancer statistics may reflect 'backwards-looking data', making it important to stay up to date on reliable information and happenings in the space.
April 11th 2025, 7:00pm
Testicular cancer is rare but highly curable, especially with early detection; treatment varies by stage, and follow-up care supports long-term health.
April 11th 2025, 5:00pm
Living with Lynch isn't easy, but it's not all doom and gloom. It's a call to live deliberately.
April 11th 2025, 1:00pm
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
Tracy Milgram-Posner Discusses BRCAStrong and Breast Cancer Support
Finally Learning to Put Myself First
Experts Discuss Next Steps in Perioperative Bladder Cancer Treatment
Signatera Guides Bladder Cancer Treatment After Surgery